alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          NOV-30-1999
<PERIOD-START>                             DEC-01-1998
<PERIOD-END>                               AUG-31-1999
<CASH>                                      14,496,459
<SECURITIES>                                         0
<RECEIVABLES>                               27,003,621
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            45,379,894
<PP&E>                                      24,898,260
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             173,834,337
<CURRENT-LIABILITIES>                       34,518,043
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        96,642
<OTHER-SE>                                  99,449,119
<TOTAL-LIABILITY-AND-EQUITY>               173,834,337
<SALES>                                              0
<TOTAL-REVENUES>                           130,430,826
<CGS>                                       87,317,186
<TOTAL-COSTS>                              117,640,015
<OTHER-EXPENSES>                               374,287
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             693,376
<INCOME-PRETAX>                             12,471,722
<INCOME-TAX>                                 5,283,123
<INCOME-CONTINUING>                          7,233,599
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 7,233,599
<EPS-BASIC>                                       0.76
<EPS-DILUTED>                                     0.72


</TABLE>
Exhibit 10.3


 


Pharmos Corporation


99 Wood Avenue South, Suite 311


Iselin, NJ 08830


 


January 3, 2008


 


Haim Aviv 


 





	
             
 	
            Re:
 	
            Pharmos Corporation (“Pharmos” or the “Company”)
 






 


Dear Haim:


 


This letter confirms the agreement between Pharmos Corporation (the “Company”) and you relating to your resignation, effective as of the date hereof, from the Board of Directors of the Company (the “Board”).  As we discussed, you are not resigning because of any disagreement on any matter relating to the Company’s operations, policies or practices.   


 


You have generously agreed to serve as a consultant to the Company following your resignation through the 2008 annual meeting of shareholders.  In connection therewith, you will make yourself available in person or by telephone, upon reasonable prior request, to the Board and its committees, as well as to members of senior management, on matters relating to general business development in your areas of expertise.  If we request you to appear periodically for meetings or the like, we will reimburse you for your reasonable expenses.  


 


In consideration for your services, we will issue to you 28,572 shares of common stock of the Company, the resale of which by you is covered by a current registration statement on Form S-8.  The shares are being issued to you in lieu of a cash consulting fee of $20,000, and the number of shares equals the amount of that fee, divided by $0.70, which is the conversion price of the convertible debentures being issued today by the Company to certain investors in a private placement transaction.  We acknowledge that pursuant to your Resignation Agreement with the Company dated as of March 20, 2007, all stock options then held by you have already become fully vested as of such date and will not expire until their respective expiration dates.  


 


By this letter, we confirm to you that you will continue to be covered by the Company’s existing directors’ and officers’ liability insurance for your acts as a director of the Company through the date hereof, and further, that the Company’s By-Laws currently provide for indemnification of you in such capacity by the Company.


 


We have also agreed to provide you with advance copy of, and the ability to review, the required public disclosure of your resignation.


 


This agreement has been approved by the Board. 


 


Thank you for the important and significant contributions you have made to Pharmos during your tenure as a director. 


 


PHARMOS CORPORATION


 


By:________________________





	
             
 	
            S. Colin Neill,
 





Chief Financial Officer


AGREED AND ACCEPTED:


 


____________________ 





	
            Haim Aviv
Exhibit 4.1 - Sample Stock Certificate





Exhibit 4.1


	Number  	  	Shares  
	NICARAGUA RISING INC. 
	INCORPORATED UNDER THE LAWS OF THE STATE OF $0.00001 
	NEVADA 200,000,000 SHARES COMMON STOCK AUTHORIZED, 
	PAR VALUE 
	  
	  	  	CUSIP  
	  	  	SEE REVERSE  
	  	  	FOR  
	This  	  	CERTAIN  
	certifies  	  	DEFINITIONS  
	that  	  	  
	is the owner of  	  	  
	  
	  
	FULLY PAID AND NON-ASSESSABLE 
	SHARES OF COMMON STOCK OF 
	  
	  
	NICARAGUA RISING INC. 
	transferable on the books of the corporation in person or by duly 
	authorized attorney upon surrender of this certificate properly 
	endorsed. This certificate and the shares represented hereby 
	are subject to the laws of the State of Nevada, and to the 
	Articles of Incorporation and Bylaws of the Corporation, 
	as now or hereafter amended. This certificate is not valid 
	unless countersigned by the Transfer Agent. WITNESS 
	the facsimile seal of the Corporation and the signature 
	of its duly authorized officers 
	  
	  
	  
	  
	PRESIDENT  	[SEAL]  	SECRETARY
John Lee JACKSON, III, Appellant, v. STATE of Florida, Appellee.

CASE NO. 1D16-1928

District Court of Appeal of Florida, First District.

Opinion filed December 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
---

EXHIBIT 32.2

|CERTIFICATION PURSUANT TO                     
|----------------------------------------------
|18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
|SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

I, Moira Ong, hereby certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

|(1) | the Annual Report on Form 10-K of Neurokine
      Pharmaceuticals Inc. for the year ended January 31, 2011 (the "Report")
      fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                                                                                                 
|(2) | the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of Neurokine Pharmaceuticals Inc.                                                              

Dated: May 10, 2011

| | /s/
      Moira Ong                        
| | -------------------------------------------
| | Moira Ong                                  
| | Chief Financial Officer                    
| | (Principal Accounting Officer and Principal
| | Financial Officer)                         
| | Neurokine Pharmaceuticals Inc.             

A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Neurokine
Pharmaceuticals Inc. and will be retained by Neurokine Pharmaceuticals Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.

---
**Exhibit      32.2**

**Certification      of Chief Financial Officer**

**Under      Section 906 of the Sarbanes-Oxley Act of 2002**

| (3)   | The              Report fully complies with the requirements of Section 13(a) or 15(d)              of              the Securities Exchange Act of 1934; and |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4)   | The              information contained in the Report fairly presents, in all material              respects, the financial condition and result of operations of the              Company. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |                                                                                                                                               |                                           |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|
|        |                                                                                                                                                    | /s/                    Gary J. Novinskie  |
|   | Gary                J. NovinskiePresident                and Chief Financial                OfficerFebruary                14,                2007 |

----
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pane l unani m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l ar g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T FRA N CI SCO BA H EN A RO SA S, P et i t i on er , v. E R I C H . H O L D E R , J r ., A tto rn e yG e n e r a l, R e s p o n d e n t. N o. 09- 70914 A ge nc yN o. A 097- 764- 199 ME MOR AN DU M *

O n P e t i t i on f

orR e vi e w of

an O r de rof

the B o ar do f I m m ig r a tio n A p p e a ls S ubm i tt e d J anuary10, 2011 ** B e f o r e : B E E Z E R , T A L L M A N , an dC A L L A H A N , C ir c u it Ju d g e s . F ranci sc o B ahena R osas , a nat i ve and ci t i ze n o f M exi co, pet i t i on s f or re vi ew of the B oard of Im m i grat i on A pp ea l s’ (“ B IA ”) order di sm i ss i ng hi s app ea l fr om an im m ig r a tio n ju d g e ’s ( “I J ” ) r e m o v a l o r d e r . W e d is m is s th e p e titio n f o rr e v ie w . 

# FI LED JAN 24 2 011 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS09- 70914 2 W e l ac k j uri sdi ct i on t o revi ew the agency’ s di sc re t i on ary det erm i nat i on that B ah e n aR o s a s la c k s th e g o o dm o r a l c h ar a c te rr e qu ir e df o rc an c e lla tio n o f

r e m o v a l. Se e Mo ra n v . A s h c r o

ft , 39 5 F . 3d10 89 , 10 91 (9th C i r. 20 05 ) ( go odm oralchar ac t er d et erm i n at i o n i s rev i ew ab l e o n l y w h ere i ti s b asedo n o n e o f th e st atu t o ry p er se e x c lu s io n s f

o u n din 8 U .S .C . § 1 1 0 1 ( f ) ) , overruled on other groun ds by Sa nchez v . H older , 5 6 0 F .3 d1 0 2 8 , 1 0 3 1 - 3 4 ( 9 th C ir . 2 0 0 9 ) ( e n b an c ) . W e l ac k j uri sdi ct i on t o con si der B ahena R osas ’ cont ent i on s thatthe IJw as bi as ed and m i sc hara ct er i ze d the evi dence agai nsthi m because B ahena R osas fa i l ed to e x h au s t th e s e is s u e s b e f o r e th e B I A . Se e B a rr o n v . A s h c r o ft , 358 F . 3d 674, 677- 7 8 ( 9 th C ir . 2 0 0 4 ) ; s e e a l s o Sa n c h ez - Cr u zv . I

NS , 25 5 F . 3d77 5, 77 9-80 (9th C i r. 20 01 ). P E T I T I O N F O R R E V I E W D I S M I S S E D .
Exhibit 32.1




CTM MEDIA HOLDINGS, INC.




Certification Pursuant to


18 U.S.C. Section 1350


(as Adopted Pursuant to Section 906


of the Sarbanes-Oxley Act Of 2002)




In connection with the Annual Report of CTM Media Holdings, Inc. (the “Company”) on Form 10-K for fiscal 2010 as filed with the Securities and Exchange Commission (the “Report”), I, Marc E. Knoller, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Date: October 29, 2010


/s/ Marc E. KnollerMarc E. KnollerChief Executive Officer




A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to CTM Media Holdings, Inc. and will be retained by CTM Media Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Russell GAILLARD v. REA BROTHERS' AUCTIONS, INC.

2016-CT-00464-COA

Supreme Court of Mississippi.

Filed: December 12, 2017 Closed: March 8, 2018

Certiorari - Denied.
Shannon COPELAND, Appellant, v. STATE of Florida, Appellee.

CASE NO. 1D16-4421

District Court of Appeal of Florida, First District.

Opinion filed November 29, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Homeland Security

###### U.S. Customs and Border Protection

# AGENCY:

U.S. Customs and Border Protection, Department of Homeland Security.

# ACTION:

Notice of accreditation and approval of Intertek USA, Inc., as a commercial gauger and laboratory.

# SUMMARY:

                        Notice is hereby given that, pursuant to 19 CFR 151.12 and 19 CFR 151.13, Intertek USA, Inc., 1145 Fourth Street, Gretna, LA 70053, has been approved to gauge and accredited to test petroleum and petroleum products, organic chemicals and vegetable oils for customs purposes, in accordance with the provisions of 19 CFR 151.12 and 19 CFR 151.13. Anyone wishing to employ this entity to conduct laboratory analyses and gauger services should request and receive written assurances from the entity that it is accredited or approved by the U.S. Customs and Border Protection to conduct the specific test or gauger service requested. Alternatively, inquiries regarding the specific test or gauger service this entity is accredited or approved to perform may be directed to the U.S. Customs and Border Protection by calling (202) 344-1060. The inquiry may also be sent to                         *cbp.labhq@dhs.gov*. Please reference the Web site listed below for a complete listing of CBP approved gaugers and accredited laboratories:                         *http://cbp.gov/​xp/​cgov/​import/​operations_​support/​labs_​scientific_​svcs/​commercial_​gaugers/​*.                    

# DATES:

The accreditation and approval of Intertek USA, Inc., as commercial gauger and laboratory became effective on December 3, 2008. The next triennial inspection date will be scheduled for December 2011.

# FOR FURTHER INFORMATION CONTACT:

                        Randall Breaux, Laboratories and Scientific Services, U.S. Customs and                               ( print page 15507)                            Border Protection, 1300 Pennsylvania Avenue, NW., Suite 1500N, Washington, DC 20229, 202-344-1060.                    

Dated: March 10, 2009.

Ira S. Reese,

Executive Director,  Laboratories and Scientific Services.

 [FR Doc. E9-7613 Filed 4-3-09; 8:45 am]

BILLING CODE 9110-06-P
Gregory W. DURANT, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-2647

District Court of Appeal of Florida, Fifth District.

Decision filed January 2, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
SERVED: JUNE 14, 2012 U.S. DEPARTMENT OF TRANSPORTATION OFFICE OF HEARINGS

WASHINGTON,DC IN THE.MATTER OF 

### GREAT LAKES AVIATION, LTD FAADOCKETNO. [TO BEASSIGNED] (Civil PenaltyAction) FDMS NO. FAA-2012- 0204 

### NOTICE OF HEARING DATES NOTICE IS HEREBY GIVENthattestimony and evidence will be heard and considered on

### November28,2012, inclusive, inthe 

### Courtroom#601 Alfred A. Arraj United · States Courthouse, 90119th Street, 2nd Floor, Denver CO. 80294. Hearings will commence at 9:00 a.m. and conclude at4:30p.m. each day. Theparties shall vacate the courthouse onorbefore 5:00p.m. eachday. Settled cases will notbe removed from the docket until the Judge receives the proper pleading(s). Pleadings maybe forwarded byfax, express mail, courier orpostal service.

. oo n .S. Administrative LawJudge Attachment- Service List

1 1· 

# o·o ...I" . 'SERVICE LIST ORIGINAL & ONE COPY Federal Aviation Administration 800 Independence Avenue, S.W. Washington, DC 20591 Attention: Hearing Docket Clerk, AGC-430 Wilbur Wright Building-Suite 2W1000 1 ONE COPY Timothy R. Thornton, Respondent's Counsel Briggs and Morgan, P.A.

2200 IDS Center 80 South 8th Street Minneapolis, MN 55402-2157 TEL: 612-977-8400 FAX: 612-977-8650 Kyle E. Lomazow, Complainant's Counsel Attorney, Office of the Regional Counsel Northwest Mountain Region, ANM-7 Federal Aviation Administration 1601 Lind Avenue, S.W. Renton, W A 98057 TEL: 425-227-1847 FAX: 425-227-1007

FDMS No. FAA-2012-0204 (Civil Penalty Action) The Honorable Richard C·Goodwin, Administrative Law Judge Office of Hearings, M-20 U.S. Department of Transportation 1200 New Jersey Avenue, S.E. (Ell-310) Washington, DC 20590 TEL: 202-366-2139 Attorney-Advisor 202-366-5121 Staff Assistant FAX: 202-366-7536

1 Service was by U.S. Mail. For service in person or by expedited courier, use the following address: Federal Aviation Administration, 600 Independence Avenue, S.W., Wilbur Wright Building-suite 2Wl000, Washington, DC 20591; Attention: Hearing Docket Clerk, AGC-430. -2-
Yvonne STEWART, Appellant, v. Dale Wayne SMITH, II, Appellee.

Case No. 5D17-63

District Court of Appeal of Florida, Fifth District.

January 2, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
#### RHP BEARINGS, LTD. NSK Bearings Europe Ltd., and NSK Corporation, Plaintiffs-Appellees, and The Barden Corporation, The Barden Corporation (U.K.) Ltd., and Fag Bearings Corporation, Plaintiffs-Appellees, v. UNITED STATES, Defendant-Appellant, and The Torrington Company, Defendant-Appellee.

No. 02-1088.

United States Court of Appeals, Federal Circuit.

April 26, 2004.

*ORDER*

Upon consideration of the United States’ unopposed motion to voluntarily dismiss its appeal, 02-1088,

IT IS ORDERED THAT:

> (1) The stay of proceedings is lifted and the motion to dismiss is granted.

> (2) All sides shall bear their own costs.
Willie Vincent Timothy THOMAS, Petitioner, v. STATE of Florida, Respondent.

CASE NO. 1D16-4893

District Court of Appeal of Florida, First District.

Opinion filed November 20, 2017.

**DECISION WITHOUT PUBLISHED OPINION**

DENIED.
| (1)   | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|-----------------|-----------------------------------------------------------------------------------------------------------------------|

| (2)   | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|           |   |                    |
|----------------|--------|-------------------------|
|           |   |                    |   |
| April 14, 2010 | By:    | /s/ Avi Lifshitz   |   |
|           |   | Avi Lifshitz            |   |
|           |   | Chief Financial Officer |   |
Patrick Jay BANKS, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-1943

District Court of Appeal of Florida, Second District.

July 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Danny W. MORGAN, DOC #H41101, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-411

District Court of Appeal of Florida, Second District.

Opinion filed October 6, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.